Alberta, Canada-based Calgary Scientific announced that it received a new FDA clearance for its diagnostic medical imaging software, called ResolutionMD, that enables providers to use the mobile software for all imaging modalities.

A Calgary Scientific spokesman told MobiHealthNews in an email that the newly cleared imaging modalities include computed radiography, digital radiography, radio-fluoroscopy, angiography, ultrasound, nuclear medicine, endoscopy and ophthalmology. The clearance does not include mammography.

The company received an FDA clearance for a similar software system in April 2013, which cleared ResolutionMD for diagnosis on iOS and Android devices. Before the most recent clearance, ResolutionMD was just cleared for computed tomography and magnetic resonance imaging.

The ResolutionMD app helps healthcare providers view images in 3D, collaborate with others, and access more patient information.

“We are excited to deliver this clearance to the institutions that rely on ResolutionMD to improve patient care," said Pierre Lemire, president and CTO of Calgary Scientific. “This is also an important advancement for all our valued partners including those who deliver custom-branded solutions, as they will be added under the Calgary Scientific registration with the FDA.”

Some Calgary Scientific partners include Siemens, Sprint, Medtronic, Accenture and Airstrip Technologies.

In 2012, Calgary Scientific did a study with the Mayo Clinic at its Phoenix location and found that radiologists using ResolutionMD Mobile versus a traditional PACS workstation were able to access CT scans of stroke victims 24 percent faster. The faster pace saved the hospital an average of 11 minutes per patient.